title: Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer.
abstract: The aim of this study was to correlate the status of the KLF6 tumour suppressor gene including loss of heterozygosity (LOH), mutation and alternative splicing in human pancreatic cancer with tumour grade and survival. Whereas neither KLF6 loss nor mutation was identified, expression of the KLF6 alternative splice forms was significantly increased in pancreatic tumour samples and cell lines. These cancers demonstrated marked cytoplasmic KLF6 expression, consistent with over-expression and accumulation of KLF6 splice form(s), which lack a nuclear localisation signal. In addition, KLF6 splicing correlated significantly with tumour stage and survival. In summary, pancreatic cancer displays a novel pattern of KLF6 dysregulation through selectively increased expression of KLF6 splice variants. Therefore, determination of KLF6 mRNA splicing levels may represent a novel biomarker predicting prognosis.
authors.affiliation: Department of Surgery, University of Heidelberg, Germany; Department of Surgery, Technische Universität München, Munich, Ismaninger Strasse 22, D-81675 Munich, Germany. mark.hartel@chir.med.tu-muenchen.de
authors.forename: Mark
authors.initials: M
authors.lastname: Hartel
authors.forename: Goutham
authors.initials: G
authors.lastname: Narla
authors.forename: Moritz N
authors.initials: MN
authors.lastname: Wente
authors.forename: Nathalia A
authors.initials: NA
authors.lastname: Giese
authors.forename: Marc E
authors.initials: ME
authors.lastname: Martignoni
authors.forename: John A
authors.initials: JA
authors.lastname: Martignetti
authors.forename: Helmut
authors.initials: H
authors.lastname: Friess
authors.forename: Scott L
authors.initials: SL
authors.lastname: Friedman
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017398:Alternative Splicing / Q000235:genetics*; D014408:Biomarkers, Tumor / Q000235:genetics; D045744:Cell Line, Tumor; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D000075723:Kruppel-Like Factor 6; D051741:Kruppel-Like Transcription Factors / Q000235:genetics*; D019656:Loss of Heterozygosity; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; C105465:KLF6 protein, human; D000075723:Kruppel-Like Factor 6; D051741:Kruppel-Like Transcription Factors; D011518:Proto-Oncogene Proteins